Literature DB >> 27278332

Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma.

Masao Ohto1, Ryu Ito2, Nei Soma2, Hiroyuki Fukuda2, Yasushi Shinohara2, Akio Sakamoto2, Fukuo Kondo3.   

Abstract

PURPOSE: The study aimed to clarify whether contrast-enhanced (CE) three-dimensional (3D) ultrasonography (US) can depict characteristic hyperstain and washout patterns in minute nodules ≤10 mm of hepatocellular carcinoma (minute HCC), and whether it serves as a potent diagnostic modality.
METHODS: CE 3D US was carried out to depict hyperstain and washout of a solitary nodule ≤10 mm in patients with liver cirrhosis. When both patterns were depicted with success, CE computed tomography (CT) and CE magnetic resonance imaging (MRI) were also carried out as part of a comparative study, and then a histological specimen was obtained by needle biopsy. The final diagnosis was based on the histopathological findings and a follow-up on the growth of nodules.
RESULTS: All 12 minute nodules exhibiting hyperstain and washout showed evidence of HCC when examined by CE 3D US. The CE CT and CE MRI examinations could depict both of these patterns, characteristic of HCC, in most of the nodules but rather less successfully than CE 3D US.
CONCLUSION: CE 3D US can depict hyperstain and washout patterns in minute HCC and serves as a potent modality for diagnosis.

Entities:  

Keywords:  Contrast enhancement; Hyperstain; Minute hepatocellular carcinoma; Three-dimensional ultrasonography; Washout

Year:  2010        PMID: 27278332     DOI: 10.1007/s10396-010-0283-6

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  40 in total

1.  Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT.

Authors:  Carlos Valls; Mònica Cos; Juan Figueras; Eduard Andía; Emilio Ramos; Anna Sánchez; Teresa Serrano; Jaume Torras
Journal:  AJR Am J Roentgenol       Date:  2004-04       Impact factor: 3.959

2.  Contrast-enhanced three-dimensional fusion sonography of small liver metastases with pathologic correlation.

Authors:  Seigo Yukisawa; Masao Ohto; Yoshio Masuya; Shinichirou Okabe; Hiroyuki Fukuda; Masaharu Yoshikawa; Masaaki Ebara; Hiromitsu Saisho; Masayuki Ohtsuka; Masaru Miyazaki; Fukuo Kondo
Journal:  J Clin Ultrasound       Date:  2007-01       Impact factor: 0.910

3.  Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers.

Authors:  Louis Libbrecht; David Cassiman; Chris Verslype; Geert Maleux; Dirk Van Hees; Jacques Pirenne; Frederik Nevens; Tania Roskams
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

4.  Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.

Authors:  T J Tsai; G Y Chau; W Y Lui; S H Tsay; K L King; C C Loong; C Y Hsia; C W Wu
Journal:  Surgery       Date:  2000-06       Impact factor: 3.982

5.  Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions.

Authors:  Carlos Nicolau; Ramon Vilana; Violeta Catalá; Luis Bianchi; Rosa Gilabert; Angeles García; Concepcio Brú
Journal:  AJR Am J Roentgenol       Date:  2006-01       Impact factor: 3.959

6.  Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Authors:  Seong Hyun Kim; Seung Hoon Kim; Jongmee Lee; Min Ju Kim; Yong Hwan Jeon; Yulri Park; Dongil Choi; Won Jae Lee; Hyo K Lim
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

7.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

8.  Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.

Authors:  Kinuyo Hatanaka; Masatoshi Kudo; Yasunori Minami; Taisuke Ueda; Chie Tatsumi; Satoshi Kitai; Shunsuke Takahashi; Tatsuo Inoue; Satoru Hagiwara; Hobyung Chung; Kazuomi Ueshima; Kiyoshi Maekawa
Journal:  Intervirology       Date:  2008-06-10       Impact factor: 1.763

9.  Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.

Authors:  Wen Luo; Kazushi Numata; Manabu Morimoto; Akito Nozaki; Yasuhiko Nagano; Kazuya Sugimori; Xiaodong Zhou; Katsuaki Tanaka
Journal:  Eur J Radiol       Date:  2008-10-18       Impact factor: 3.528

10.  Cirrhosis or chronic hepatitis: evaluation of small (<or=2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging.

Authors:  Ayame Shimizu; Katsuyoshi Ito; Shinji Koike; Takeshi Fujita; Kensaku Shimizu; Naofumi Matsunaga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

View more
  2 in total

1.  Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Xiao-Wen Huang; Yang Huang; Li-da Chen; Zhu Wang; Zheng Yang; Jin-Ya Liu; Xiao-Yan Xie; Ming-De Lu; Shun-Li Shen; Wei Wang
Journal:  J Med Ultrason (2001)       Date:  2017-10-20       Impact factor: 1.314

2.  Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment.

Authors:  Hiroyuki Fukuda; Kazushi Numata; Koji Hara; Akito Nozaki; Masaaki Kondo; Makoto Chuma; Masayuki Nakano; Akinori Nozawa; Shin Maeda; Katsuaki Tanaka
Journal:  J Cancer       Date:  2018-06-14       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.